Skip to main content
Coreline Soft Co., Ltd logo

Coreline Soft Co., Ltd — Investor Relations & Filings

Ticker · 384470 ISIN · KR7384470001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 163 across all filing types
Latest filing 2025-01-03 Director's Dealing
Country KR South Korea
Listing KO 384470

About Coreline Soft Co., Ltd

https://www.corelinesoft.com/en/

Coreline Soft is a medical artificial intelligence company specializing in the development of software solutions for the analysis of thoracic medical images. Its flagship AI platform, AVIEW, is designed for healthcare professionals to automate and streamline diagnostic workflows. The platform utilizes Explainable AI (XAI) to analyze chest CT scans, enabling the simultaneous detection and quantification of multiple conditions from a single scan. Key applications include lung cancer screening through pulmonary nodule analysis, COPD assessment via emphysema quantification, and coronary artery calcification analysis. The company's technology focuses on facilitating the early detection of diseases, often before the onset of clinical symptoms, to improve diagnostic accuracy and efficiency.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (장내매수 - open market purchases) of a specific executive (CFO Jung Woo-seok) of Coreline Soft. This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which corresponds to the 'Director's Dealing' category.
2025-01-03 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of holding an Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of the record date. Since it is a regulatory announcement that does not fit into specific categories like dividend announcements or share issues, it is classified as a general regulatory filing.
2024-12-18 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Correction Report) for a previously filed stock option grant. It details changes to the number of recipients and the number of shares granted due to employee resignations. This type of filing is a standard regulatory disclosure regarding capital structure and equity compensation, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance).
2024-12-12 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Coreline Soft, covering the period from 2024.01.01 to 2024.09.30. It contains detailed business descriptions, product information, financial data, and research activities. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean
소송등의제기ㆍ신청(일정금액이상의청구) (성과급 등 청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a lawsuit ('소송등의제기ㆍ신청') filed against the company Coreline Soft. It details the nature of the claim (performance bonus), the amount claimed, the court involved, and the company's planned legal response. This fits the definition of a Legal Proceedings Report (LTR).
2024-08-30 Korean
주식매수선택권부여에관한신고
Remuneration Information Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees and executives, including the number of shares, exercise price, and valuation methodology. Since this relates to the issuance of new shares or capital-related instruments (stock options), it falls under the category of share issues or capital changes.
2024-08-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.